103 related articles for article (PubMed ID: 10775035)
1. Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein.
Kerkhoff E; Fedorov LM; Siefken R; Walter AO; Papadopoulos T; Rapp UR
Cell Growth Differ; 2000 Apr; 11(4):185-90. PubMed ID: 10775035
[TBL] [Abstract][Full Text] [Related]
2. BAG-1 haplo-insufficiency impairs lung tumorigenesis.
Götz R; Kramer BW; Camarero G; Rapp UR
BMC Cancer; 2004 Nov; 4():85. PubMed ID: 15560850
[TBL] [Abstract][Full Text] [Related]
3. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR
BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070
[TBL] [Abstract][Full Text] [Related]
4. Use of mitogenic cascade blockers for treatment of C-Raf induced lung adenoma in vivo: CI-1040 strongly reduces growth and improves lung structure.
Kramer BW; Götz R; Rapp UR
BMC Cancer; 2004 Jun; 4():24. PubMed ID: 15171791
[TBL] [Abstract][Full Text] [Related]
5. Towards a lung adenocarcinoma proteome map: studies with SP-C/c-raf transgenic mice.
Rütters H; Zürbig P; Halter R; Borlak J
Proteomics; 2006 May; 6(10):3127-37. PubMed ID: 16688788
[TBL] [Abstract][Full Text] [Related]
6. Serum proteomics of lung adenocarcinomas induced by targeted overexpression of c-raf in alveolar epithelium identifies candidate biomarkers.
Chatterji B; Borlak J
Proteomics; 2007 Nov; 7(21):3980-91. PubMed ID: 17902193
[TBL] [Abstract][Full Text] [Related]
7. p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions.
Kalkuhl A; Troppmair J; Buchmann A; Stinchcombe S; Buenemann CL; Rapp UR; Kaestner K; Schwarz M
Hepatology; 1998 Apr; 27(4):1081-8. PubMed ID: 9537449
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors.
Reamon-Buettner SM; Borlak J
Cancer Res; 2008 Sep; 68(18):7587-96. PubMed ID: 18794147
[TBL] [Abstract][Full Text] [Related]
9. Growth of transgenic RAF-induced lung adenomas is increased in mice with a disrupted PPARbeta/delta gene.
Müller-Brüsselbach S; Ebrahimsade S; Jäkel J; Eckhardt J; Rapp UR; Peters JM; Moll R; Müller R
Int J Oncol; 2007 Sep; 31(3):607-11. PubMed ID: 17671688
[TBL] [Abstract][Full Text] [Related]
10. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
11. Loss of p53 in craf-induced transgenic lung adenoma leads to tumor acceleration and phenotypic switch.
Fedorov LM; Papadopoulos T; Tyrsin OY; Twardzik T; Götz R; Rapp UR
Cancer Res; 2003 May; 63(9):2268-77. PubMed ID: 12727849
[TBL] [Abstract][Full Text] [Related]
12. Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice.
Olschläger V; Pleschka S; Fischer T; Rziha HJ; Wurzer W; Stitz L; Rapp UR; Ludwig S; Planz O
Oncogene; 2004 Aug; 23(39):6639-46. PubMed ID: 15235583
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 determines susceptibility to induction of lung cancer by oncogenic CRaf.
Fedorov LM; Tyrsin OY; Papadopoulos T; Camarero G; Götz R; Rapp UR
Cancer Res; 2002 Nov; 62(21):6297-303. PubMed ID: 12414660
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
15. A 2-DE MALDI-TOF study to identify disease regulated serum proteins in lung cancer of c-myc transgenic mice.
Chatterji B; Borlak J
Proteomics; 2009 Feb; 9(4):1044-56. PubMed ID: 19180532
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of c-Raf expression induces apoptosis in tumor cells.
Lau QC; Brüsselbach S; Müller R
Oncogene; 1998 Apr; 16(14):1899-902. PubMed ID: 9583688
[TBL] [Abstract][Full Text] [Related]
17. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
18. Opposite role of Ras in tumor necrosis factor-alpha-induced cell cycle regulation: competition for Raf kinase.
Park SJ; Kim YY; Lim JY; Seo GJ; Kim J; Park SI; Park BJ
Biochem Biophys Res Commun; 2001 Oct; 287(5):1140-7. PubMed ID: 11587542
[TBL] [Abstract][Full Text] [Related]
19. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.
Kasiappan R; Shih HJ; Chu KL; Chen WT; Liu HP; Huang SF; Choy CO; Shu CL; Din R; Chu JS; Hsu HL
Mol Cancer Res; 2009 Apr; 7(4):536-48. PubMed ID: 19372582
[TBL] [Abstract][Full Text] [Related]
20. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
